Telehealth Startups
Telehealth Startups
Delivering care across state lines gets complicated fast. We help telehealth founders build compliant platforms and clinical structures from the ground up - before regulators make it expensive to fix.
Telehealth compliance is a multi-state problem.
A telehealth startup isn't just a technology company - it's a clinical operation subject to the licensing laws, prescribing rules, supervision requirements, and corporate practice restrictions of every state where a patient receives care. For platforms operating in the GLP-1, peptide, or compounding space, the regulatory exposure is even sharper - FDA enforcement posture, 503A pharmacy relationships, and state prescribing rules are all moving targets. Getting the structure right at the start is far less costly than unwinding it later.
Multi-state licensing strategy
Practicing medicine or nursing across state lines requires licensure in each state where care is delivered - and the rules vary significantly. We analyze your target markets, identify applicable licensing requirements for your clinical staff, and advise on interstate compacts that may streamline the process.
- State-by-state licensing analysis for physicians, NPs, and PAs
- Interstate Medical Licensure Compact (IMLC) guidance
- Nurse Licensure Compact (NLC) and APRN Compact applicability
- Licensing roadmap aligned to your launch markets
Corporate structure and CPOM compliance
Telehealth companies operating in multiple states face CPOM restrictions in each of them - and those rules are not uniform. We design entity structures and PC/MSO arrangements that satisfy the corporate practice of medicine doctrine across your target states while remaining workable for investors and operators.
- Multi-state CPOM analysis
- PC/MSO structuring for telehealth platforms
- Ownership and control compliance across jurisdictions
- Investor-compatible entity design
Prescribing rules and clinical protocols
Telehealth prescribing is one of the most heavily regulated areas in digital health - and for platforms prescribing GLP-1s, peptides, or other high-demand therapeutics, the scrutiny is heightened. We advise on Ryan Haight Act compliance, state prescribing restrictions, controlled substance rules, and the clinical protocol requirements that govern what your providers can and cannot do remotely.
- Ryan Haight Act and DEA telemedicine rules
- GLP-1 and peptide prescribing compliance
- State-specific prescribing restrictions
- Clinical protocol development and review
Compounding pharmacy relationships and FDA compliance
Telehealth platforms that source compounded medications - including semaglutide, tirzepatide, and peptide therapies - operate in a rapidly shifting regulatory environment. FDA enforcement against 503A compounding pharmacies has intensified, and the rules governing what can be compounded, by whom, and under what conditions continue to evolve. We help platforms understand their exposure, structure compliant pharmacy relationships, and build the documentation and oversight practices that reduce risk as the landscape changes.
- 503A compounding pharmacy compliance and relationship structuring
- FDA enforcement landscape for compounded GLP-1s and peptides
- Compounding restrictions and drug shortage rules
- Pharmacy agreement review and vendor due diligence
Supervision and collaboration agreements
NPs and PAs delivering telehealth care often require physician supervision or collaboration agreements that satisfy the requirements of each state where they practice. We draft and structure these agreements to meet state-specific standards while keeping your clinical operations practical and scalable.
- State-specific supervision and collaboration requirements
- Physician collaboration agreement drafting
- Multi-state agreement structuring
- Scope of practice analysis by state
HIPAA and platform compliance
Telehealth platforms handle protected health information at scale. We help you build a HIPAA compliance program suited to a digital-first clinical operation - covering privacy policies, security risk assessments, business associate agreements with technology vendors, and workforce protocols.
- HIPAA privacy and security program development
- Business associate agreements with technology vendors
- Security risk assessments
- Patient consent and notice of privacy practices
Ready to build it right?
Schedule a consultation and we'll map the regulatory requirements specific to your telehealth model and target markets.